iWOW Technology Limited Raises S\$15 Million in Fully Subscribed Placement to Accelerate Growth
Key Highlights
- S\$15.0 million raised through placement of 66,667,000 new shares at S\$0.225 per share; fully subscribed by institutional and strategic investors.
- Strong participation from renowned institutional investors, including fund managers under Singapore’s Equity Market Development Programme (EQDP), and strategic healthcare investors.
- Net proceeds of approximately S\$14.5 million to be used for scaling clinical nutrition manufacturing, overseas expansion, R&D, sales and marketing, funding acquisition, and working capital.
- Placement shares represent approximately 18.8% of the enlarged share capital and are expected to begin trading on SGX Catalist on 30 July 2026.
- Significant new shareholder: Dr. Lim Cheok Peng, former Managing Director of IHH Healthcare, brings industry expertise and potential access to healthcare networks.
- Strategic move post-acquisition of The Gentle Group, strengthening iWOW’s position in the longevity economy with AgeTech, Clinical Nutrition, and IoT businesses.
In-Depth Analysis
Overview of the Placement
iWOW Technology Limited has successfully completed a placement of 66,667,000 new ordinary shares at S\$0.225 per share, raising gross proceeds of S\$15.0 million. The placement was fully subscribed, reflecting robust demand from institutional, accredited, and strategic investors, and was approved unanimously at the Company’s EGM on 16 July 2026. ZICO Capital Pte. Ltd. acted as the placement agent, with Maybank Securities Pte. Ltd. as sub-placement agent.
Significant Shareholder and Market Implications
The placement introduces several high-profile institutional investors to iWOW’s shareholder base, including fund managers under the Singapore EQDP and strategic healthcare investors. Notably, Dr. Lim Cheok Peng, a respected figure in the healthcare sector and former MD of IHH Healthcare, has invested, lending credibility and potentially opening regional expansion opportunities via his extensive network.
Institutional investors participating include Amova Asset Management, Areca Capital Sdn Bhd, Asdew Acquisitions, Avanda Investment Management, Azure Capital, Ginko-AGT Global Growth Fund, ICH Synergrowth Fund, Lion Global Investors, Tokio Marine Life Insurance Singapore, UOB Asset Management, and Value Partners Hong Kong Limited.
This broadening of the institutional base is expected to improve the Company’s market visibility, trading liquidity, and market depth, which could positively impact share price performance over time. The high-quality investor mix serves as a strong endorsement of iWOW’s growth strategy and business model.
Strategic Use of Funds
- 25–35%: Expansion of manufacturing capacity for GentleFoods, aiming for a fivefold increase to meet growing demand for texture-modified, dysphagia-friendly meals.
- 15%: International expansion through B2B partnerships, including pilot deployments in the United States and Japan.
- 15%: Research & Development for new AgeTech, IoT solutions, and Clinical Nutrition offerings.
- 10–15% each: Sales and marketing; and funding part of the consideration/acquisition of The Gentle Group and post-acquisition integration.
- 15–20%: General working capital.
The net proceeds of S\$14.5 million (after S\$0.5 million in estimated expenses) will provide iWOW with significant financial flexibility. The focus on scaling manufacturing, expanding internationally, and advancing R&D is likely to enhance revenue streams and strengthen the Company’s competitive position in the fast-growing longevity and healthcare sectors.
Growth Strategy and Business Model
Following its acquisition of The Gentle Group, iWOW is building an integrated platform targeting the needs of ageing societies, structured around three pillars:
- Safety: The “Buddy of Parents” (BOP) solution offers AI-powered monitoring, emergency response, and fall detection to support independent living for seniors.
- Sustenance: Through The Gentle Group, iWOW provides clinically formulated nutrition products for seniors managing conditions such as dysphagia, diabetes, and kidney disease.
- Social Connection: Collaboration with GetSetUp enables older adults to stay connected, digitally engaged, and engaged in lifelong learning.
These complementary businesses create a differentiated ecosystem to address the diverse needs of ageing populations and drive long-term customer engagement.
Capital Structure and Listing Update
After the placement, iWOW’s enlarged issued share capital stands at 353,724,025 shares (excluding treasury shares), with the new Placement Shares accounting for approximately 18.8%. The Placement Shares will be listed and quoted on the Catalist board of the SGX from 9:00 a.m. on 30 July 2026.
Leadership Commentary
Substantial shareholder and Non-Executive Chairman Mr. Soo Kee Wee expressed strong support for the placement, highlighting that the participation of high-quality investors validates iWOW’s long-term vision and strategy. He noted that the capital raised would accelerate growth and create lasting value for both new and existing shareholders, positioning iWOW as a leading player in the longevity economy.
Potential Share Price Impact and Investor Takeaways
- The successful placement at a premium, strong institutional interest, and addition of high-profile strategic investors can significantly boost market confidence, potentially leading to a rerating of iWOW’s shares.
- Expansion into international markets and a fivefold increase in manufacturing capacity signal robust growth prospects and could drive future revenue and earnings growth.
- Strengthened financial flexibility post-placement supports continued investment in R&D and business expansion, offering upside potential for shareholders.
- Integration of The Gentle Group and increased focus on the longevity economy position iWOW at the intersection of demographic trends and healthcare innovation, which could attract further investor interest.
About iWOW Technology Limited
iWOW Technology Limited is a Singapore Exchange-listed technology company focused on purpose-driven innovation in wireless communications, IoT, and AgeTech solutions. The Company is known for the Buddy of Parents (BOP) brand and has been recognized with the DBS Foundation Impact Beyond Award. For more details, visit: www.iwow.com.sg and www.buddyofparents.com.
Investor Relations Contact
Emily Choo
Mobile: +65 9734 6565
Email: [email protected]
Disclaimer
This article is for informational purposes only and does not constitute an offer or solicitation to buy or sell any securities. It is not tailored to the individual investment objectives or financial situation of any reader. Please consult your own financial advisor before making any investment decisions. The information presented may contain forward-looking statements, which involve risks and uncertainties. Actual outcomes may differ materially. Past performance is not indicative of future results.
iWOW科技有限公司完成1,500万新元定向增发，助力下一阶段增长（中文版）
要点回顾
- 通过发行66,667,000股新普通股，每股定价S\$0.225，成功募集1,500万新元，获得机构与战略投资者的全额认购。
- 新加坡股权市场发展计划(EQDP)旗下基金管理人及知名医疗投资者积极参与。
- 净募资约1,450万新元，将用于临床营养制造扩产、海外扩张、研发、市场营销、收购及整合The Gentle Group，以及一般营运资金。
- 增发股份占扩大后股本约18.8%，预计2026年7月30日早上9点起在新交所Catalist板块挂牌交易。
- 重要新股东：前IHH Healthcare董事总经理林作彭医生，其医疗资源和行业经验有望推动iWOW区域扩张。
- 定向增发为收购The Gentle Group后的战略举措，巩固公司在银发经济领域的AgeTech、临床营养及物联网业务布局。
详细解读
iWOW科技有限公司以每股S\$0.225定向增发66,667,000股新普通股，募集总额1,500万新元。此次定增获得机构、合格及战略投资者的积极认购，并于2026年7月16日公司股东特别大会上获得全票通过。ZICO Capital为主承销商，Maybank Securities为副承销商。
重要股东与市场影响
定增引入多家重量级机构投资者，包括EQDP旗下基金管理人与医疗领域战略投资者。特别值得关注的是，前IHH Healthcare董事总经理林作彭医生成为股东，为公司在区域医疗扩展带来丰富资源和声誉。
参与定增的机构包括Amova Asset Management、Areca Capital、Asdew Acquisitions、Avanda Investment Management、Azure Capital、Ginko-AGT Global Growth Fund、ICH Synergrowth Fund、Lion Global Investors、Tokio Marine Life Insurance Singapore、UOB Asset Management和Value Partners Hong Kong Limited。
机构股东基础的扩展预计将提升公司市场关注度、交易活跃度和市场深度，有助于提升股价表现。高质量投资者的加入，是对iWOW发展战略和模式的有力背书。
资金用途与战略部署
- 25–35%：扩大GentleFoods产能，目标提升至现有5倍，满足吞咽障碍友好型餐食等市场需求。
- 15%：通过B2B合作，推进美国、日本等国际市场试点。
- 15%：投向AgeTech、IoT及临床营养的新产品研发。
- 各10–15%：市场销售推广；支付The Gentle Group部分收购款及整合费用。
- 15–20%：一般营运资金。
净募资1,450万新元为iWOW提供充足弹药，助力产能扩张、国际化布局和技术创新，推动公司营收和竞争力持续提升。
业务模式与增长展望
收购The Gentle Group后，iWOW打造以“银发经济”为核心的综合平台，三大支柱包括：
- 安全：“Buddy of Parents”智能看护方案，集AI监测、紧急响应及跌倒检测于一体，提升老年人独立生活质量。
- 营养：通过The Gentle Group，针对吞咽障碍、糖尿病、肾病等老年健康问题，提供专业临床营养产品。
- 社交：携手GetSetUp，帮助老年用户保持社交活跃与数字学习。
三项业务协同，形成差异化生态，有效锁定老年群体多元需求，增强客户黏性与生命周期价值。
资本结构与上市进展
定增完成后，iWOW股本扩大至353,724,025股（不含库藏股），本次新股占比约18.8%。新股将于2026年7月30日9:00起在新交所Catalist板块挂牌交易。
管理层观点
大股东兼非执行主席苏基伟先生表示，欢迎高素质投资者加入，资本实力的提升和投资者的认可将加速公司发展，助力iWOW成为银发经济领域的领军企业，为新老股东持续创造价值。
对股东的潜在影响与投资提示
- 成功定增、高质量机构战略投资人加入，有望提升市场信心及公司估值。
- 国际市场扩张与产能大幅提升，预示未来收入和盈利增长潜力。
- 财务弹性增强，支持持续研发与业务拓展，提升长期投资回报预期。
- 聚焦银发经济，叠加医疗科技创新，有望吸引更多市场关注。
关于iWOW科技有限公司
iWOW科技有限公司是一家在新加坡交易所上市的科技公司，专注于无线通信、物联网与老龄科技创新，旗下“Buddy of Parents”品牌荣获DBS基金会Impact Beyond大奖。详情请访问：www.iwow.com.sg 与 www.buddyofparents.com。
投资者联系
Emily Choo
电话: +65 9734 6565
邮箱: [email protected]
免责声明
本文仅供参考，不构成买卖任何证券的要约或邀请。内容未针对任何个人投资目标或财务状况定制，请在投资前咨询专业顾问。文中或含前瞻性陈述，涉及风险与不确定性，实际结果可能大相径庭。历史业绩不代表未来表现。
